Market Value219,310,000
Total Holdings33
File Date2021-02-11
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
JAZZ / Jazz Pharmaceuticals plc
KALV / KalVista Pharmaceuticals, Inc.
VTGN / Vistagen Therapeutics, Inc.
QDEL / QuidelOrtho Corporation
SELB / Selecta Biosciences Inc
CDXS / Codexis, Inc.
WVE / Wave Life Sciences Ltd.
ITCI / Intra-Cellular Therapies, Inc.
GLTO / Galecto, Inc.
EQ / Equillium, Inc.
HZNP / Horizon Therapeutics Plc
CYTK / Cytokinetics, Incorporated
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
ELDN / Eledon Pharmaceuticals, Inc.
BMRN / BioMarin Pharmaceutical Inc.
PMVP / PMV Pharmaceuticals, Inc.
GMTX / Gemini Therapeutics Inc
UNH / UnitedHealth Group Incorporated
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
NSTG / NanoString Technologies, Inc.
PACB / Pacific Biosciences of California, Inc.
FLDM / Standard BioTools Inc
FBRX / Forte Biosciences, Inc.
TPTX / Turning Point Therapeutics Inc
FATE / Fate Therapeutics, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
CCCC / C4 Therapeutics, Inc.
VTRS / Viatris Inc.
GRAY / Graybug Vision Inc
TXG / 10x Genomics, Inc.
MEIP / MEI Pharma, Inc.
STRO / Sutro Biopharma, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ATRS / Antares Pharma Inc
NCNA / NuCana plc - Depositary Receipt (Common Stock)
ILMN / Illumina, Inc.
BDSX / Biodesix, Inc.
PODD / Insulet Corporation
GH / Guardant Health, Inc.
ARNA / Arena Pharmaceuticals Inc
GBT / Global Blood Therapeutics Inc.
RCUS / Arcus Biosciences, Inc.
BLSA / BCLS Acquisition Corp - Class A
AVDL / Avadel Pharmaceuticals plc
KURA / Kura Oncology, Inc.
SAGE / Sage Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.